Analyst consensus rating

Dogwood Therapeutics Analyst Rating: none

Direct answer

Dogwood Therapeutics's consensus rating is none.

3 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $14.00.
Forecast evidence checked November 22, 2026.

Get free Dogwood Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Current price
$1.04
Average price target
$14.00
High price target
$15.00
Low price target
$12.00
Low target gap
+1,059.4%
Target upside
+1,252.7%
High target gap
+1,349.3%
Target range width
289.9%
Consensus rating
none
Analysts
3
Evidence date
November 22, 2026
Valid through
November 29, 2026

Read the frequently asked questions.

What is the analyst consensus rating for Dogwood Therapeutics?

Dogwood Therapeutics has a verified none consensus. The same dataset has an average price target of $14.00.

How far are Dogwood Therapeutics's low and high targets from the recorded price?

The low target implies +1,059.4%, while the high target implies +1,349.3%.

How many analysts are included in Dogwood Therapeutics's consensus?

The verified consensus includes 3 analysts.

How is Dogwood Therapeutics's target upside or downside calculated?

The average target of $14.00 is divided by the recorded price of $1.04, then one is subtracted to produce +1,252.7%. This does not guarantee a future return.

When was Dogwood Therapeutics's analyst forecast verified?

The data was verified on 2026-11-22. The dataset is valid through 2026-11-29.